My Investment Portfolio (September 2024)

STI ended 3rd quarter of the year at around 3585 points, up around 4% as compared to last month. STI reached a 17 year high level this month as optimism came back into the markets on key export numbers and efforts to revive the local market. Also, investors cheered US Fed jumbo rate cut and China stimulus measures to revive the economy.

For my top 30 holdings this month, Isetan was out of the list after the stock had been acquired via Scheme of Arrangement. Metro Holdings returned to the list as investors accumulated China related stocks. Other main contributors include Hong Fok, Sembcorp Industries, Wing Tai, F&N, DBS and Bukit Sembawang Estates. Detractors include PM Data and Multi-Chem.

I have bought the following companies from the market this month - ABR, AP Oil, BBR, Bonvests, Brook Crompton, Bund Center, Chemical Industries, Chuan Hup, City Developments, Credit Bureau Asia, Delfi, EnGro, Far East Orchard, Hiap Hoe, Ho Bee Land, Hong Leong Finance, Hor Kew, Hotel Grand Central, Hotung, Indofood Agri, IPC Corp, Jardine Matheson, Kencana Agri, Kingsmen, KSH, Lion AsiaPac, Lum Chang, Nam Lee, New Toyo, OUE Healthcare, PNE Industries, SBS Transit, Shangri-La Asia, Singapore Land Group, Singapore Shipping, Singapura Finance, Tuan Sing, Tye Soon and Yeo Hiap Seng. I have also reduced my stake in Beng Kuang (warrants), First Sponsor (warrants) and Jadason.

My stakes in Isetan and Best World had also been acquired via Scheme of Arrangement and selective capital reduction respectively.

I have participated in the following preferential offer/rights issue - CapitaLand Integrated Commercial Trust.

I have also participated in the following scrip dividend schemes - Global Investments and Jardine Matheson.

Next month, companies with financial year ending 30 June 2024 will be holding their AGMs. As markets had advanced quite a bit this month, I will continue to invest but at a more slower pace. As usual, I will be more conservative in terms of portfolio positioning and will also be holding more cash.

My S'pore Stock Portfolio - Top Holdings, cash investment only (correct as at 30 September 2024)

Top 30 Holdings (Sing$ Denominated shares)

1. iFAST

2. Amara Holdings

3. Hong Fok

4. Hong Leong Finance

5. PM Data

6. Bonvests

7. Sing Investment & Finance

8. Sembcorp Industries

9. Hotel Properties

10. The Hour Glass

11. LHT

12. Jardine C&C

13. Wing Tai

14. Hotel Grand Central

15. Stamford Land

16. Far East Orchard

17. Bukit Sembawang Estates

18. Samudera Shipping

19. Multi-Chem

20. Yeo Hiap Seng

21. F&N

22. Metro Holdings

23. DBS

24. CapitaLand Ascendas REIT

25. Great Eastern (Suspended)

26. Singapore Land Group

27. Tat Seng

28. SingTel

29. Singapura Finance

30. SGX

Top 5 Holdings (US$ Denominated shares)

1. Mandarin Oriental
2. Hongkong Land
3. Jardine Matheson

4. TZ Da Ren Tang
5. DFI Retail Group

Top Holdings (HK$ Denominated shares)

1. Shangri-La Asia

2. Tan Chong International

Top Holdings (Aust$ Denominated shares)
1. AV Jennings

Top 5 Holdings (CPF OA investment)
1. Streettracks STI ETF

2. Keppel Ltd
3. CapitaLand Integrated Commercial Trust

4. CapitaLand Ascendas REIT
5. PM Data

My Hong Kong Stock Portfolio
1. Peace Mark Holdings - Under Voluntary Liquidation
2. Alpha Professional Holdings Ltd (formerly known as Z-Obee Holdings Ltd)

My Australia Stock Portfolio
1. GPS Alliance Holdings Limited

My Unlisted Company Portfolio
1. Iconic Global Limited
2. Dongshan Group Ltd (formerly known as Greatronic Limited)
3. General Magnetics
4. Fastech Synergy
5. Memory Devices
6. Jurong Tech - In liquidation - Compulsory winding up (Insolvency)
7. FM Holdings
8. FerroChina - Under Liquidation
9. FirstLink Investments
10. NEL Group
11. Jets Technics
12. Hongwei Technologies Limited (In Provisional Liquidation)
13. FDS Networks Group
14. China Oilfield Technology
15. China Milk Products Group - Under Liquidation
16. Pacific Healthcare
17. Fung Choi Media - In Liquidation
18. Europtronic Group - In liquidation - Compulsory winding up (Insolvency)
19. Attilan Group
20. Transcorp - In liquidation - Compulsory winding up (Insolvency)

21. Equatoriale Holdings  

22. China Haida

23. Chaswood Resources

My Unit Trust Asset Allocation

Dear all,

After nearly one year, I guess it is time for another summary on my unit trust asset allocation. You can refer to my previous one at the link below:

https://ghchua.blogspot.com/2023/09/my-unit-trust-asset-allocation.html

For asset classes, I have done nothing much other than consistently adding onto the list of unit trusts that I had been holding for CPF Investments. I have again been defensive for the past one year or so, and therefore increased my allocation to short duration bond fund again. The other asset classes are obviously down correspondingly in terms of percentage of allocation, with my additional allocation to the short duration bond fund.

For geographic exposure, Global, Singapore and US funds were the out performers in the portfolio. India, Malaysia and Taiwan funds also did well.

Laggards continued to be funds with exposure to China. Though I don't specifically hold any China funds, Asia Pacific Excluding Japan, Emerging Markets and Asia excluding Japan regional funds do have decent exposure to that market, which dragged down their performance. Other laggards include funds invested in Indonesia and Thailand. 

Going forward, my strategy is to add onto existing funds, while continue to maintain a defensive positioning in terms of asset allocation. I will continue to allocate more to fixed income instead of equity, with emphasis on shorter duration to mitigate interest rate fluctuations.

Asset Class

Equity 81.2%

Balanced 12.87%

Short Duration Bond 4.95%

Fixed Income 0.98%

Geographic

Global 20.27%

Asia Pacific Excluding Japan 16.32%

Emerging Markets 12.66%

Japan 11.43%

US 8.71%

Singapore 7.68%

Asia excluding Japan 5.68%

Taiwan 3.32%

Europe including UK 3.23%

Indonesia 2.73%

India 2.58%

Thailand 2.39%

Malaysia 1.71%

Korea 1.29%

Welcome any comments (if any) on my unit trust asset allocation.